Condition: Androgenetic Alopecia (AGA) · Healthy Volunteers - Male and Female · Sponsor: Absci Pty Ltd.
The goal of this clinical trial is to learn if ABS-201 (a new medication) is safe and tolerable when used to improve hair growth in men and women. The trial will start with healthy volunteers and if safe, will treat participants with certain types of hair loss. The main questions it aims to answer are: What medical problems, if any, do participants experience when taking a single dose or many doses of ABS-201? How does the medication, ABS-201, compare to placebo (a look alike substance that does not contain any medication). Participants who qualify for the trial will receive either ABS-201 or a placebo, and visit the study clinic for scheduled checkups and tests for approximately 1 year.
This description comes directly from the study's public registry record.
Charles Romano, MPH · +1.860.857.4560 · cromano@absci.com
Always discuss trial participation with your own doctor first.
| Momentum Darlinghurst | Sydney, New South Wales, Australia | Recruiting |
| Nucleus Network Brisbane | Brisbane, Queensland, Australia | Recruiting |
| Sinclair Dermatology | Melbourne, Victoria, Australia | Recruiting |
| Nucleus Network | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07317544